<DOC>
	<DOCNO>NCT01847482</DOCNO>
	<brief_summary>A multicenter , single-arm , prospective , interventional trial evaluate therapeutic hypothermia intravascular temperature management ( IVTM ) post-cardiogenic cardiac arrest , post-return spontaneous circulation ( ROSC ) patient Japan . The objective study verify therapeutic hypothermia perform intravascular cool use investigational device ( IVTM ) control body temperature appropriately post-cardiogenic cardiac arrest , post-ROSC patient .</brief_summary>
	<brief_title>Therapeutic Hypothermia With IntraVascular Temperature Management ( IVTM ) Post-Cardiogenic Cardiac Arrest Post-Return Spontaneous Circulation Patients Japan</brief_title>
	<detailed_description />
	<mesh_term>Heart Arrest</mesh_term>
	<mesh_term>Hypothermia</mesh_term>
	<criteria>1 . Nontraumatic inhospital outofhospital cardiac arrest 2 . Unwitnessed cardiac arrest ( Ventricular fibrillation ) , witness cardiac arrest ( ventricular fibrillation , pulseless electrical activity , asystole within 15 minute follow onset ) 3 . Patient least 20 year age less 80 year age consent give 4 . In judgement investigator subinvestigator , patient unable follow verbal instruction 5 . Therapeutic hypothermia use investigational device initiate within six hour Return Spontaneous Circulation ( ROSC ) 6 . Written consent obtain legally acceptable representative 1 . Traumatic cardiac arrest ( blunt trauma , penetrate trauma , burn , exsanguination , suffocation , smoke inhalation , near drowning , etc ) 2 . Accidental hypothermia core body temperature le 35.0Â°C 3 . Pregnant child bear potential 4 . Patient give indicated Do Not Resuscitate ( DNR ) order 5 . Femoral venous access contraindicate previous surgey , medical history , anatomy like 6 . An inferior vena cava filter place 7 . Patient severe bleeding ( Pulmonary hemorrhage , gastrointestinal hemorrhage , etc . ) 8 . Intracranial hemorrhage confirm CT scan 9 . Hemodynamic instability despite use vasopressor agent cardiac stimulant 10 . Heparin hypersensitivity 11 . Serious systemic infectious disease ( sepsis , etc . ) 12 . Platelet count less 30,000/mm3 13 . Serious hepatic dysfunction 14 . Serious renal impairment 15 . Using percutaneous cardiopulmonary support ( PCPS ) 16 . Using continuous hemodiafiltration ( CHDF ) 17 . Therapeutic hypothermia otherwise implement ROSC start study ( exclude rapid infusion nonglucosecontaining cold electrolyte fluid , nonglucosecontaining cold plasma volume expander ) 18 . The patient 's core body temperature monitor 19 . Currently participate another clinical trial participate another clinical trial within past six month 20. judgement investigator subinvestigator , participation clinical trial inappropriate patient</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Cardiac arrest</keyword>
	<keyword>Return Spontaneous Circulation ( ROSC )</keyword>
	<keyword>IntraVascular Temperature Management ( IVTM )</keyword>
	<keyword>Therapeutic Hypothermia</keyword>
	<keyword>Japan</keyword>
</DOC>